CMA takes DNA sequencing deal to Phase II
The UK’s Competition and Markets Authority has referred DNA analysis company Illumina’s acquisition of Pacific Biosciences for an in-depth review.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.